What is Sofregen Medical?
Sofregen Medical Inc. is dedicated to advancing medical practice through the development and provision of purified silk protein biomaterials. Their innovative product line, including the Silk Voice Injectable Implant, is engineered to improve surgical outcomes by promoting soft tissue regeneration, particularly in aesthetic procedures such as vocal fold medialization. The company's mission is to empower skilled medical aesthetic practitioners by leveraging the scientific potential of silk protein, aiming to set new benchmarks in aesthetic medicine.
How much funding has Sofregen Medical raised?
Sofregen Medical has raised a total of $19.4M across 4 funding rounds:
Angel/Seed
$1.6M
Series A
$9.7M
Series B
$8M
Debt
$150K
Angel/Seed (2014): $1.6M, investors not publicly disclosed
Series A (2016): $9.7M led by Polaris Partners
Series B (2019): $8M supported by Anzu Partners
Debt (2020): $150K featuring PPP
Key Investors in Sofregen Medical
Anzu Partners
Anzu Partners is an investment firm focused on breakthrough technologies in clean tech, industrial, and life sciences sectors. They collaborate with a diverse team to support founders in bringing innovative solutions to market, providing expertise in business development and market positioning.
Polaris Partners
Polaris Partners is a venture capital firm specializing in backing transformational companies in the biotech and healthcare sectors. They partner with entrepreneurs to create successful business solutions, providing coaching, advice, and resources for growth.
What's next for Sofregen Medical?
With the recent strategic investment and a history of substantial capital infusion, Sofregen Medical is poised for accelerated growth and product development. The company's focus on natural biomaterials and regenerative medicine aligns with growing market trends in minimally invasive aesthetic procedures. Future endeavors will likely involve expanding the application of their silk protein technology, further clinical validation, and broader market penetration, solidifying their position as a leader in advanced biomaterials for aesthetic and reconstructive medicine.
See full Sofregen Medical company page
